Systemic Atherosclerosis and Cross Vascular Risk Prediction

This direction is merged into another direction: multi-vessel disease markers. Its last version stays readable and citable here.

Version 1 of 114 papers16 conceptsfrozen 2026-10-04

Atherosclerosis is often treated as a localized problem—a blockage in the heart, a narrowing in the neck, or a clot in the leg. However, a growing body of evidence suggests that these are merely different windows into the same systemic failure. When one arterial bed is compromised, it serves as a "red flag" for the entire vascular network.

The Systemic Nature of Vascular Decay

The fundamental intuition behind this research is that the biological processes driving arterial disease—inflammation, endothelial dysfunction, and plaque accumulation—do not respect anatomical boundaries. If the environment in the blood is pro-thrombotic or inflammatory, every vessel is at risk.

Yong Liu and colleagues demonstrated this by showing that patients with coronary heart disease exhibit significant impairment in the blood vessels of their limbs. This suggests that measuring vascular health in an accessible arm or leg can provide a reliable proxy for the state of the heart. Similarly, Zhiqing Chen found that branch retinal vein occlusion—a condition in the eye—is actually a manifestation of generalized arterial stiffening. These localized events are not isolated accidents; they are symptoms of a systemic condition.

Accessible Arteries as Diagnostic Proxies

Because deep-seated vessels like the coronary or carotid arteries are difficult to monitor routinely, researchers are looking for "accessible windows" to predict hidden risks. The radial artery (at the wrist) and the peripheral arteries of the legs have emerged as powerful indicators.

  • The Radial Map: Rui Yan used high-resolution imaging to map atherosclerosis in the radial artery, finding that its presence is a strong clinical indicator for multi-vessel coronary artery disease.
  • The Leg-Brain Link: Woo‐Sung Yun discovered that 14% of patients with severe peripheral arterial disease (PAD) also harbor "silent" but critical carotid artery stenosis. This suggests that advanced atherosclerosis in the lower extremities is a high-fidelity signal for potential strokes.
  • The Diabetic Foot: In elderly patients, Siyuan Zhou showed that simple peripheral indicators like the Ankle-Brachial Index are the most critical predictors for complex complications like diabetic foot, reinforcing the role of peripheral health as a primary driver of systemic decline.

Biomarkers of Global Vascular Risk

Beyond physical imaging, the research identifies several systemic biomarkers that act as quantitative tools for risk. These markers often come from unexpected places, reflecting the body's interconnected metabolic and vascular health.

Zhi-huang Chen found that high levels of free Prostate-Specific Antigen (fPSA)—usually a marker for prostate health—correlate with a 2.5-fold increase in cardiovascular disease risk. Meanwhile, Tao Yao established that elevated levels of the liver enzyme GGT can predict the severity of intracranial arterial calcification and stroke mortality.

On a molecular level, Yan‐Wei Hu identified the long noncoding RNA NEXN-AS1 as a protective "shield" against vascular inflammation. When these molecular or enzymatic markers are out of balance, they reflect a systemic environment ripe for atherosclerotic progression across all vascular beds.

Clinical Implications for Screening

The practical takeaway of this "systemic" view is the necessity of cross-screening. If a patient presents with disease in one area, clinicians should have a high index of suspicion for others.

Young‐Nam Roh and Dong‐Ik Kim argue that because ischemic heart disease is a strong predictor for carotid narrowing, targeted ultrasound screening in heart patients can prevent "silent" strokes. This is echoed by Qianyin Huang, who found that the presence of PAD in patients with stable heart disease significantly increases the risk of death and major cardiovascular events.

By treating the vascular system as a single, interconnected organ, these researchers are moving toward a model where localized symptoms are used to map and mitigate global cardiovascular risk.

Papers in this version

History & citationVersion 1 · 2026-10-04

Merged into another direction · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_systemic_atherosclerosis_and_cross_vascu_19c119fc,
  title = {Systemic Atherosclerosis and Cross Vascular Risk Prediction},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/systemic-atherosclerosis-and-cross-vascular-risk-prediction/rdr_19c119fc41884a7e81d773110003f8c5},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_systemic_atherosclerosis_and_cross_vascu_19c119fc_v1,
  title = {Systemic Atherosclerosis and Cross Vascular Risk Prediction},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/systemic-atherosclerosis-and-cross-vascular-risk-prediction/rdr_19c119fc41884a7e81d773110003f8c5/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}